These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 24623147

  • 1. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
    Franzén S, Friederich-Persson M, Fasching A, Hansell P, Nangaku M, Palm F.
    Am J Physiol Renal Physiol; 2014 May 15; 306(10):F1171-8. PubMed ID: 24623147
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.
    Persson P, Fasching A, Teerlink T, Hansell P, Palm F.
    Hypertension; 2014 Aug 15; 64(2):323-9. PubMed ID: 24866144
    [Abstract] [Full Text] [Related]

  • 4. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P, Zuccalà A, Sturani A.
    Postgrad Med J; 1988 Aug 15; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pathogenicity of glomerular hyperfiltration, a question of glomerular tolerance?].
    Wüstenberg PW, Dabels J.
    Z Gesamte Inn Med; 1990 Apr 15; 45(8):210-4. PubMed ID: 2198716
    [Abstract] [Full Text] [Related]

  • 7. Activation of hypoxia-inducible factors prevents diabetic nephropathy.
    Nordquist L, Friederich-Persson M, Fasching A, Liss P, Shoji K, Nangaku M, Hansell P, Palm F.
    J Am Soc Nephrol; 2015 Feb 15; 26(2):328-38. PubMed ID: 25183809
    [Abstract] [Full Text] [Related]

  • 8. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L, Gabbai FB, Liberti ME, Sagliocca A, Conte G, Minutolo R.
    Am J Kidney Dis; 2014 Jul 15; 64(1):16-24. PubMed ID: 24673844
    [Abstract] [Full Text] [Related]

  • 9. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R, Spinas GA.
    Praxis (Bern 1994); 1995 Oct 31; 84(44):1265-71. PubMed ID: 7491450
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN, Paige A, Spires D, Kojima N, Kyle PB, Garrett MR, Roman RJ, Williams JM.
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct 01; 305(7):R727-34. PubMed ID: 23926133
    [Abstract] [Full Text] [Related]

  • 11. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
    Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL.
    Diabetes; 2006 Nov 01; 55(11):3112-20. PubMed ID: 17065350
    [Abstract] [Full Text] [Related]

  • 12. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.
    Qi Z, Fujita H, Jin J, Davis LS, Wang Y, Fogo AB, Breyer MD.
    Diabetes; 2005 Sep 01; 54(9):2628-37. PubMed ID: 16123351
    [Abstract] [Full Text] [Related]

  • 13. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP, Kasiske BL, Keane WF.
    FASEB J; 1988 May 01; 2(8):2339-47. PubMed ID: 3282959
    [Abstract] [Full Text] [Related]

  • 14. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T, Tomoda F, Kinuno H, Inoue H, Takata M.
    Acta Physiol Scand; 2005 May 01; 184(1):73-81. PubMed ID: 15847646
    [Abstract] [Full Text] [Related]

  • 15. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Levine DZ.
    Clin Sci (Lond); 2008 Jan 01; 114(2):109-18. PubMed ID: 18062776
    [Abstract] [Full Text] [Related]

  • 16. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S, Starnes J, Shi S, Lonis B, Tran R.
    J Am Soc Nephrol; 2007 Nov 01; 18(11):2945-52. PubMed ID: 17928507
    [Abstract] [Full Text] [Related]

  • 17. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y, Hirano K, Nagata M, Gannon MA, Takahashi K, Harris RC, Breyer MD, Takahashi T.
    Am J Physiol Renal Physiol; 2006 Dec 01; 291(6):F1315-22. PubMed ID: 16705146
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C, Brown R, Head GA, Cooper ME, Thomas MC.
    Am J Physiol Renal Physiol; 2014 Apr 01; 306(7):F773-80. PubMed ID: 24477684
    [Abstract] [Full Text] [Related]

  • 19. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
    Spencer MW, Mühlfeld AS, Segerer S, Hudkins KL, Kirk E, LeBoeuf RC, Alpers CE.
    Am J Nephrol; 2004 Apr 01; 24(1):20-31. PubMed ID: 14671436
    [Abstract] [Full Text] [Related]

  • 20. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R, Jayakumar C, Chen F, Fulton D, Stepp D, Gansevoort RT, Ramesh G.
    J Am Soc Nephrol; 2016 Mar 01; 27(3):745-65. PubMed ID: 26334030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.